Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Newrzela

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Leukemia|May 31, 2012
T-cell receptor diversity prevents T-cell lymphoma developmentS Newrzela, N Al-Ghaili, T Heinrich, et al.
Leukemia|December 15, 2015
Highly recurrent mutations of SGK1, DUSP2 and JUNB in nodular lymphocyte predominant Hodgkin lymphomaS Hartmann, B Schuhmacher, T Rausch, et al.
Oncogene|July 4, 2012
Overexpression of the anti-apoptotic protein AVEN contributes to increased malignancy in hematopoietic neoplasmsM Eißmann, I M Melzer, S B M Fernández, et al.
Nature|February 18, 2026
Individualized mRNA vaccines evoke durable T cell immunity in adjuvant TNBCU Sahin, M Schmidt, E Derhovanessian, et al.
Leukemia|April 9, 2016
Re-activation of mitochondrial apoptosis inhibits T-cell lymphoma survival and treatment resistanceS Spinner, G Crispatzu, J-H Yi, et al.
Nature Communications|February 17, 2018
Actionable perturbations of damage responses by TCL1/ATM and epigenetic lesions form the basis of T-PLLA Schrader, G Crispatzu, S Oberbeck, et al.
Blood|December 10, 2020
Noncanonical effector functions of the T-memory-like T-PLL cell are shaped by cooperative TCL1A and TCR signalingS Oberbeck, A Schrader, K Warner, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Leukemia|May 31, 2012
T-cell receptor diversity prevents T-cell lymphoma developmentS Newrzela, N Al-Ghaili, T Heinrich, et al.
Leukemia|December 15, 2015
Highly recurrent mutations of SGK1, DUSP2 and JUNB in nodular lymphocyte predominant Hodgkin lymphomaS Hartmann, B Schuhmacher, T Rausch, et al.
Oncogene|July 4, 2012
Overexpression of the anti-apoptotic protein AVEN contributes to increased malignancy in hematopoietic neoplasmsM Eißmann, I M Melzer, S B M Fernández, et al.
Nature|February 18, 2026
Individualized mRNA vaccines evoke durable T cell immunity in adjuvant TNBCU Sahin, M Schmidt, E Derhovanessian, et al.
Leukemia|April 9, 2016
Re-activation of mitochondrial apoptosis inhibits T-cell lymphoma survival and treatment resistanceS Spinner, G Crispatzu, J-H Yi, et al.
Nature Communications|February 17, 2018
Actionable perturbations of damage responses by TCL1/ATM and epigenetic lesions form the basis of T-PLLA Schrader, G Crispatzu, S Oberbeck, et al.
Blood|December 10, 2020
Noncanonical effector functions of the T-memory-like T-PLL cell are shaped by cooperative TCL1A and TCR signalingS Oberbeck, A Schrader, K Warner, et al.
Pageof 1